Variable | ACHBLF group (n = 80) | CHB group (n = 60) | HC group (n = 30) | |
---|---|---|---|---|
GC group (n = 45) | CM group (n = 35) | |||
Male (%) | 31 (68.9) | 25 (71.4) | 43 (61.4) | 19 (63.3) |
Age (years) | 44.0 (32.0–51.5) | 45.0 (37.0–57.0) | 42.0 (34.0–48.5) | 36.5 (28.3–42.8) |
HBeAg + (%) | 20 (44.4) | 18 (51.4) | 28 (46.7) | NA |
Log10 [HBV DNA] | 4.3 (3.3–5.9) | 4.3 (3.9–6.7) | 4.5 (3.2–5.5) | NA |
ALT (U/L) | 238.0 (136.5–513.0) | 150.0 (101.0–373.0) | 90.0 (56.5–148.5) | 18.0 (12.8–23.0) |
AST (U/L) | 164.0 (94.0–310.5) | 130.0 (85.0–179.0) | 65.5 (38.5–91.5) | 18.0 (15.8–23.0) |
TBIL (mg/dL) | 12.5 (10.8–19.4) | 13.3 (10.4–22.8) | 0.9 (0.7–1.1) | 0.7 (0.5–0.8) |
ALB (g/L) | 30.8 (28.6–36.0) | 32.7 (28.9–35.7) | 42.8 (40.4–45.9) | 49.5 (47.2–51.3) |
Cr (mg./dL) | 0.7 (0.6–0.9) | 0.8 (0.6–0.9) | 0.7 (0.6–0.8) | 0.7 (0.6–0.8) |
INR | 1.7 (1.6–1.9) | 1.8 (1.6–2.1) | 1.0 (1.0–1.1) | 1.0 (1.0–1.1) |
PTA (%) | 35.0 (30.0–37.5) | 34.0 (30.0–38.0) | 83.5 (73.5–97.0) | 96.0 (88.8–104.0) |
MELD score | 19.8 (18.2–22.8) | 20.6 (18.7–25.1) | NA | NA |
SOCS1 methylation level | 23.8 (7.9–61.6) | 34.2 (2.4–71.7) | 1.8 (1.0–3.0) | 0.8 (0.6–1.3) |